Advaxis, Inc. announced the appointment of Molly Henderson as Executive Vice President and Chief Financial Officer, effective June 6, 2018. Ms. Henderson joins Advaxis from Cedar Cliff, LLC, where she served as a financial and business consultant to high-growth entrepreneurial companies. Previously she was Chief Financial Officer at Iovance Biotherapeutics, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.261 USD | -8.01% | +4.40% | -60.87% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.87% | 11.13M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Advaxis, Inc. Appoints Molly Henderson as Executive Vice President and Chief Financial Officer